Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas
Open Access
- 5 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 28 (2), 1167-1177
- https://doi.org/10.1245/s10434-020-08926-4
Abstract
Background Small bowel adenocarcinoma is a relatively rare cancer, often diagnosed in an advanced stage. In localized and resectable disease, surgery alone or in combination with adjuvant chemotherapy is the mainstay of treatment. In the recently published National Comprehensive Cancer Network Clinical Practice guidelines, criteria for selecting patients with stage II small bowel adenocarcinoma to receive adjuvant chemotherapy are provided, and they are mainly extrapolated from studies on colorectal cancer. Patients and Methods In the present study, we aimed to verify whether mismatch repair deficiency phenotype, high-risk pathologic features (including T4, positive resection margins and a low number of lymph nodes harvested), as well as tumor histologic subtype, were associated with cancer-specific survival in 66 stage II non-ampullary small bowel adenocarcinoma patients, collected through the Small Bowel Cancer Italian Consortium. A central histopathology review was performed. Mismatch repair deficiency was tested by immunohistochemistry for MLH1, MSH2, MSH6 and PMS2, and confirmed by polymerase chain reaction for microsatellite instability. Results We identified mismatch repair deficiency, glandular/medullary histologic subtype, and celiac disease as significant predictors of favorable cancer-specific survival using univariable analysis with retained significance in bivariable models adjusted for pT stage. Among the high-risk features, only T4 showed a significant association with an increased risk of death; however, its prognostic value was not independent of mismatch repair status. Conclusions Mismatch repair protein expression, histologic subtype, association with celiac disease, and, in the mismatch repair proficient subset only, T stage, may help identify patients who may benefit from adjuvant chemotherapy. Graphic AbstractKeywords
Funding Information
- Fondazione IRCCS Policlinico San Matteo (Ministero Italiano della Salute)
This publication has 36 references indexed in Scilit:
- Prognostic relevance of lymph node ratio and total lymph node count for small bowel adenocarcinomaSurgery, 2015
- Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS StudiesClinical Cancer Research, 2014
- Small bowel adenocarcinomas—existing evidence and evolving paradigmsNature Reviews Clinical Oncology, 2013
- A Population-Based Comparison of Adenocarcinoma of the Large and Small Intestine: Insights Into a Rare DiseaseAnnals of Surgical Oncology, 2011
- Prognostic value of lymph node evaluation in small bowel adenocarcinomaCancer, 2010
- Immunophenotype and molecular characterisation of adenocarcinoma of the small intestineBritish Journal of Cancer, 2009
- Perineural Invasion Is an Independent Predictor of Outcome in Colorectal CancerJournal of Clinical Oncology, 2009
- Coeliac diseaseThe Lancet, 2009
- The Role of Defective Mismatch Repair in Small Bowel Adenocarcinoma in Celiac DiseaseCancer Research, 2004
- Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resectionJournal of Surgical Oncology, 2003